# Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen

> **NCT00633009** · PHASE2 · COMPLETED · sponsor: **Nielsen BioSciences, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **BIOLOGICAL:** Leishmania tropica Skin Test Antigen (LtSTA)
- **BIOLOGICAL:** Leishmania tropica Skin Test Antigen Placebo (Placebo)

## Key facts

- **NCT ID:** NCT00633009
- **Lead sponsor:** Nielsen BioSciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-09
- **Final completion:** 2010-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633009, "Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00633009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*